Relationship Between Baseline Prostate-specific Antigen on Cancer Detection and Prostate Cancer Death: Long-term Follow-up from the European Randomized Study of Screening for Prostate Cancer

The Association Between Age, Prostate Cancer Risk, and Higher Gleason Score in a Long-term Screening Program: Results from the Göteborg-1 Prostate Cancer Screening Trial

(2022) Rebecka Arnsrud Godtman et al.   EUROPEAN UROLOGY

A randomized trial of risk‐adapted screening for prostate cancer in young men—Results of the first screening round of the PROBASE trial

(2022) Christian Arsov et al.   INTERNATIONAL JOURNAL OF CANCER

Adherence to a risk‐adapted screening strategy for prostate cancer: First results of the PROBASE trial

(2022) Agne Krilaviciute et al.   INTERNATIONAL JOURNAL OF CANCER

Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021

(2021) Hendrik Van Poppel et al.   EUROPEAN UROLOGY

MRI-Targeted or Standard Biopsy in Prostate Cancer Screening

(2021) Martin Eklund et al.   NEW ENGLAND JOURNAL OF MEDICINE

Population‐based randomized trial of screening for clinically significant prostate cancer ProScreen: a pilot study

(2021) Antti Rannikko et al.   BJU INTERNATIONAL

Early Detection of Prostate Cancer in 2020 and Beyond: Facts and Recommendations for the European Union and the European Commission

(2020) Hendrik Van Poppel et al.   EUROPEAN UROLOGY

EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent

(2020) Nicolas Mottet et al.   EUROPEAN UROLOGY

A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer

(2019) Jonas Hugosson et al.   EUROPEAN UROLOGY

The c-index is not proper for the evaluation of $t$-year predicted risks

(2018) Paul Blanche et al.   BIOSTATISTICS

Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer

(2016) Mark A. Preston et al.   JOURNAL OF CLINICAL ONCOLOGY

Intermediate-Term Risk of Prostate Cancer is Directly Related to Baseline Prostate Specific Antigen: Implications for Reducing the Burden of Prostate Specific Antigen Screening

(2015) Jonathan Gelfond et al.   JOURNAL OF UROLOGY

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

(2014) Fritz H Schröder et al.   LANCET

Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort study

(2014) S. Carlsson et al.   BMJ-British Medical Journal

Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study

(2013) A. J. Vickers et al.   BMJ-British Medical Journal

Positive predictive value of prostate biopsy indicated by prostate-specific-antigen-based prostate cancer screening: trends over time in a European randomized trial*

(2012) Leonard P. Bokhorst et al.   BJU INTERNATIONAL

The impact of PLCO control arm contamination on perceived PSA screening efficacy

(2012) Roman Gulati et al.   CANCER CAUSES & CONTROL

Screening for Prostate Cancer Decreases the Risk of Developing Metastatic Disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC)

(2012) Fritz H. Schröder et al.   EUROPEAN UROLOGY

Age-specific and sex-specific mortality in 187 countries, 1970–2010: a systematic analysis for the Global Burden of Disease Study 2010

(2012) Haidong Wang et al.   LANCET

Prostate-Cancer Mortality at 11 Years of Follow-up

(2012) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prostate Cancer Incidence and Disease-Specific Survival of Men with Initial Prostate-Specific Antigen Less Than 3.0ng/ml Who Are Participating in ERSPC Rotterdam

(2011) Meelan Bul et al.   EUROPEAN UROLOGY

Balancing the harms and benefits of early detection of prostate cancer

(2010) Pim J. van Leeuwen et al.   CANCER

Screening and Prostate-Cancer Mortality in a Randomized European Study

(2009) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE